Pharma Companies Urge G-20 Leaders to Protect their IP Rights
shot by IP News Shots / 7:02 pm on 07 May, 2021
A group of pharmaceutical companies have written in a report to the G-20 leaders about the lack of protection for intellectual property (IP) rights and its effects on innovation. Companies including Novartis AG, Sanofi FP, AstraZeneca plc and Johnson & Johnson have told the G-20 leaders that weakening the IP rights protection will lead to a reduction in investments and will affect innovation adversely. The companies have urged the G-20 to act towards better protection of IP rights for the health and life sciences industries.
Read More at: https://economictimes.indiatimes.com/news/international/world-news/medical-cos-seek-g-20-protection-for-patents/articleshow/82440352.cms